Daniel Rubin

Daniel Rubin

Radiologist

Bio:   Daniel L. Rubin, MD, MS is Associate Professor of Biomedical Data Science, Radiology, Medicine (Biomedical Informatics Research), and Ophthalmology (courtesy) at Stanford University. He is Principal Investigator of two centers in the National Cancer Institute's Quantitative Imaging Network (QIN), Chair of the Informatics Committee of the ECOG-ACRIN cooperative group, past-Chair of the QIN Executive Committee, and past Chair of the RadLex Steering Committee of the Radiological Society of North America. His NIH-funded research program focuses on quantitative imaging and integrating imaging data with clinical and molecular data to discover imaging phenotypes that can predict the underlying biology, define disease subtypes, and personalize treatment. He is a Fellow of the American College of Medical Informatics and has published over 160 scientific publications in biomedical imaging informatics and radiology.

Imaging Clinic (Radiology)

Stanford Hospital

Professional Education

  • Residency: Stanford University School of Medicine Registrar (1990) CA
  • Internship: Stanford University School of Medicine Registrar (1986) CA
  • Medical Education: Stanford University School of Medicine Registrar (1985) CA
  • Residency: Stanford University Hospital (1991)
  • Board Certification: Diagnostic Radiology, American Board of Radiology (1990)

Honors & Awards

  • caBIG Connecting Collaborators Award, National Cancer Institute (2010)
  • Certificate of Merit, Radiological Society of North America (2009)
  • Cum Laude Award, Radiological Society of North America (2006)
  • Cum Laude Award, Radiological Society of North America (2008)
  • Distinguished Investigator Award, Academy for Radiology & Biomedical Imaging Research (2017)

Administrative Appointments

  • Director of Biomedical Informatics, Stanford Cancer Institute (2016 - Present)
  • Director, Scholarly Concentration in Informatics and Data Driven Medicine, Stanford School of Medicine (2011 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.